Showing 21-30 of 629 results for "".
Detecting Multiple Sclerosis Earlier: PRLs and the Evolving McDonald Diagnostic Criteria
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/detecting-multiple-sclerosis-earlier-prls-and-the-evolving-mcdonald-diagnostic-criteria/54390/This episode explores new evidence showing that paramagnetic rim lesions (PRLs) are highly prevalent early in multiple sclerosis (MS) and can differentiate MS from mimics with striking accuracy. Daniel Ontaneda, MD, PhD, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, and Pascal Sati, PhLeveraging AI To Optimize Epilepsy Patient Care
https://practicalneurology.com/programs/practical-neurology/leveraging-ai-to-optimize-epilepsy-patient-care/39906/Pierre D’Haese, PhD, West Virginia University Rockefeller Neuroscience Institute, Morgantown, WV, discuses how AI-driven automation can surface missing MRIs, EEGs, and neuropsychological evaluations to close diagnostic care gaps in epilepsy management.SMA Experience: Episode 2
https://practicalneurology.com/diseases-diagnoses/neuromuscular/sma-experience-episode-2/30081/Neuromusclar disease expert Diana Bharucha-Goebel, MD, PhD chats with Traci High, mother of two patients with SMA about how the SMA treatment landscape, and her childens' lives, have changed over the past 15 years.Translating CORE-VNS Study Outcomes Into Epilepsy Care
https://practicalneurology.com/programs/practical-neurology/translating-core-vns-study-outcomes-into-epilepsy-care/39908/Maxine Dibue, PhD, LivaNova, London, UK, details 36-month prospective registry data on adjunctive vagus nerve stimulation in patients with drug-resistant epilepsy, focusing on the durability of seizure reduction across seizure types and the implications of long-term real-world outcomes for clinicalThe Impact of High Efficacy DMTs on Paramagnetic Rim Lesions
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-impact-of-high-efficacy-dmts-on-paramagnetic-rim-lesions/35439/Jack Reeves, PhD, researcher at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, discusses results of a study which demonstrated that high efficacy disease-modifying therapies may help prevent the development of paramagnetic rim lesions and slow the progressiMastering Migraine
https://practicalneurology.com/programs/practical-neurology/mastering-migraine/35575/Melody Barthelemy, a human resources specialist, details her experiences living with migraine, including strategies for tracking episodes and thriving with a busy career. She is joined by Dawn C. Buse, PhD, Clinical Professor, Albert Einstein College of Medicine, New York, NY, who discusses recent rBiomarker Testing Modalities for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/biomarker-testing-modalities-for-alzheimer-disease/35432/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors physicians should consider when ordering a biomarker test and recommendations for how physicians should communicate the need for a particular test with their pTraumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/traumatic-brain-injury/31246/David Brody, MD, PhD, Chief Science Officer, Center for Neuroscience and Regenerative Medicine, Uniformed Services University of the Health Sciences, provides a comprehensive overview of TBI, including sports-related concussion, TBI in various populations, and common sequelae, including mood disordeNew Guidelines for the Assessment of Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/new-guidelines-for-the-assessment-of-traumatic-brain-injury/35727/Beth McQuiston, MD, RD, Medical Director, Abbott, Abbott Park, IL, and David Okonkwo, MD, PhD, Professor of Neurological Surgery, the University of Pittsburgh, Pittsburg, PA, describe some of the important updates to guidelines for the assessment of traumatic brain injury, including biomarker testinPart I: Early Alzheimer Disease Detection with the DAC-SP Blueprint Program: Overview of a Scalable Health System Approach
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/part-i-early-alzheimer-disease-detection-with-the-dac-sp-blueprint-program-overview-of-a-scalable-health-system-approach/54690/Elyse Perweiler, RN, MPP, Professor, Rowan–Virtua School of Osteopathic Medicine, Stratford, NJ, and Tim MacLeod, PhD, Program Director, Healthcare System Preparedness Program, Davos Alzheimer’s Collaborative (DAC), Toronto, Ontario, Canada, examine how health systems can operationalize early cognit